title: [Pharmacological profile and clinical evidence in patients with primary osteoporosis treated with intravenous ibandronate].
authors.forename: Ayako
authors.initials: A
authors.lastname: Shiraishi
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology*; D001842:Bone and Bones / Q000378:metabolism; D002762:Cholecalciferol / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology*; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D017886:Durapatite / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D000077557:Ibandronic Acid; D007262:Infusions, Intravenous; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D002762:Cholecalciferol; D017886:Durapatite; D000077557:Ibandronic Acid